Popular Articles
Benefits Of Grapefruit

MAGI's 2009 Clinical Research Conference - WEST
If you are a clinical research novice or veteran with a study sponsor, research site, or CRO in a corporate, academic or other organization, you will find a comprehensive program that focuses on your current needs and broadens your knowledge. MAGI conferences feature balanced co-presentations from sponsors, sites and CROs, real-life examples, practical tips, and lots of interaction and networking. This year"s conference will feature:
generic viagra online
SCRIP's 'Best-In-Class' Reporting Recognised By Industry - Journalist Malani Guha Wins Advances In Renal Cancer Journalists' Award
Journalist, Malini Guha, has won the prestigious new Advances in Renal Cancer Journalists" Award - Europe for her article "New Advances Deliver Fresh Hope in Kidney Cancer" - which was published in Scrip World Pharmaceutical News on February 13th 2009.
News of the day
Breakthrough In The Quantum Control Of Light Could Impact Drug Design
Researchers at UC Santa Barbara have recently demonstrated a breakthrough in the quantum control of photons, the energy quanta of light. This is a significant result in quantum computation, and could eventually have implications in banking, drug design, and other applications.
Mental Health

Total Knee Replacement Appears Cost-Effective In Older Adults

Total knee replacement (arthroplasty) appears to be a cost-effective procedure for older adults with advanced osteoarthritis, according to a report in the June 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The procedure appears to be cost-effective across all patient risk groups, and appeared more costly and less effective in low-volume centers than in high-volume centers. Approximately 12 percent of adults older than 60 have symptoms of knee osteoarthritis, and their direct medical costs are estimated to range from $1,000 to $4,100 per person per year, according to background information in the article. "Total knee arthroplasty is a frequently performed and effective procedure that relieves pain and improves functional status in patients with end-stage knee osteoarthritis," the authors write. "Almost 500,000 total knee arthroplasties were performed in the United States in 2005 at a cost exceeding $11 billion. Projections indicate dramatic growth in the use of total knee arthroplasty over the next two decades." Elena Losina, Ph.D., of Brigham and Women"s Hospital and the Boston University School of Public Health, and colleagues developed a computer simulation model and populated it with Medicare claims data and cost and outcomes data from national and multinational s. They then projected lifetime costs and quality-adjusted life expectancy-or the number of years remaining of good health-for patients at different levels of risk and receiving total knee arthroplasty at high-volume or low-volume facilities. Overall, having a total knee arthroplasty increased quality-adjusted life expectancy of the Medicare population (average age 74) from 6.822 to 7.957 quality-adjusted life years (years of life in perfect health). Total costs increased from $37,100 among individuals not receiving total knee arthroplasty to $57,900 per person undergoing total knee arthroplasty, resulting in a cost-effectiveness ratio of $18,300 per quality-adjusted life year. Therefore, total knee arthroplasty is a highly cost-effective procedure for the management of end-stage knee osteoarthritis compared with non-surgical treatments and is within the range of accepted cost-effectiveness for other musculoskeletal procedures, the authors note. "This result is robust across a broad range of assumptions regarding both patient risk and hospital volume," they write. "For patients who choose to undergo total knee arthroplasty, hospital volume plays an important role: regardless of patient risk level, higher-volume centers consistently deliver better outcomes. But the additional survival benefits associated with high-volume centers provide limited cost-effectiveness benefits for high-risk patients deliberating between medium- and high-volume centers." Even procedures performed in low-volume centers were more cost-effective than not having total knee arthroplasty, regardless of the patient"s risk of complications. "Clinicians, patients and policy makers should consider the relative cost-effectiveness of total knee arthroplasty in making decisions about who should undergo total knee arthroplasty, where and when," the authors conclude. Arch Intern Med. 2009;169[12]:1113-1121 Archives of Internal Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):